No Journal Glut

It is difficult to judge whether readers were meant to take seriously Jeffrey B. Moran’s article “The Journal Glut: Scientific Publications Out Of Control” (The Scientist, July 10, 1989, page 11). On the assumption that he was not being facetious in at least the first half of his article, I offer the following reaction. The “proliferation of scholarly journals” is unfortunately a knee-jerk cliche used by those who fail to give serious thought to the problem. Jou

Written byAllan Wittman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It is difficult to judge whether readers were meant to take seriously Jeffrey B. Moran’s article “The Journal Glut: Scientific Publications Out Of Control” (The Scientist, July 10, 1989, page 11). On the assumption that he was not being facetious in at least the first half of his article, I offer the following reaction.

The “proliferation of scholarly journals” is unfortunately a knee-jerk cliche used by those who fail to give serious thought to the problem. Journals, by their nature, are chronicles of their times. In the 40 years since Biochemica and Biophysica Acta (BBA) [which Moran used to illustrate the “out-of-control” proliferation of science publications] consisted of one volume, there has been an information explosion, especially in science and engineering. No serious reader of The Scientist will deny that scientific discovery during the latter half of this century has been extraordinary in the history of mankind and continues to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies